MedInvest Oncology Investor Conference, in Palo Alto, CA, on December 5-6, 2023

We are thrilled to announce @GenEndeavor’s participation in the upcoming MedInvest Oncology Investor Conference, in Palo Alto, CA, on December 5-6, 2023.

At the event, GenEndeavor will showcase our molecular diagnostics technology platform, which lowers the limit of detection of rare mutations and rapidly identifies pathogens for sensitive and real-time genetic and infectious disease detection. GenEndeavor’s current focus is to translate this new platform into an early-detection ovarian cancer screening test.